<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2020-08-12" version="185">
<accession>P43119</accession>
<name>PI2R_HUMAN</name>
<protein>
<recommendedName>
<fullName>Prostacyclin receptor</fullName>
</recommendedName>
<alternativeName>
<fullName>Prostaglandin I2 receptor</fullName>
<shortName>PGI receptor</shortName>
<shortName>PGI2 receptor</shortName>
</alternativeName>
<alternativeName>
<fullName>Prostanoid IP receptor</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTGIR</name>
<name type="synonym">PRIPR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="12173" last="12178">
<title>Cloning and expression of a cDNA for the human prostanoid IP receptor.</title>
<authorList>
<person name="Boie Y."/>
<person name="Rushmore T.H."/>
<person name="Darmon-Goodwin A."/>
<person name="Grygorczyk R."/>
<person name="Slipetz D.M."/>
<person name="Metters K.M."/>
<person name="Abramovitz M."/>
</authorList>
<dbReference type="PubMed" id="7512962"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="FEBS Lett." volume="344" first="74" last="78">
<title>Cloning and expression of a cDNA for the human prostacyclin receptor.</title>
<authorList>
<person name="Katsuyama M."/>
<person name="Sugimoto Y."/>
<person name="Namba T."/>
<person name="Irie A."/>
<person name="Negishi M."/>
<person name="Narumiya S."/>
<person name="Ichikawa A."/>
</authorList>
<dbReference type="PubMed" id="7514139"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)00355-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Circulation" volume="90" first="1643" last="1647">
<title>Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.</title>
<authorList>
<person name="Nakagawa O."/>
<person name="Tanaka I."/>
<person name="Usui T."/>
<person name="Harada M."/>
<person name="Sasaki Y."/>
<person name="Itoh H."/>
<person name="Yoshimasa T."/>
<person name="Namba T."/>
<person name="Narumiya S."/>
<person name="Nakao K."/>
</authorList>
<dbReference type="PubMed" id="7923647"/>
<dbReference type="DOI" id="10.1161/01.cir.90.4.1643"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="Genomics" volume="27" first="142" last="148">
<title>Structural organization and chromosomal assignment of the human prostacyclin receptor gene.</title>
<authorList>
<person name="Ogawa Y."/>
<person name="Tanaka I."/>
<person name="Inoue M."/>
<person name="Yoshitake Y."/>
<person name="Isse N."/>
<person name="Nakagawa O."/>
<person name="Usui T."/>
<person name="Itoh H."/>
<person name="Yoshimasa T."/>
<person name="Narumiya S."/>
</authorList>
<dbReference type="PubMed" id="7665161"/>
<dbReference type="DOI" id="10.1006/geno.1995.1016"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
<title>cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).</title>
<authorList>
<person name="Warren C.N."/>
<person name="Aronstam R.S."/>
<person name="Sharma S.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Eur. J. Biochem." volume="269" first="1714" last="1725">
<title>Investigation of a functional requirement for isoprenylation by the human prostacyclin receptor.</title>
<authorList>
<person name="Miggin S.M."/>
<person name="Lawler O.A."/>
<person name="Kinsella B.T."/>
</authorList>
<dbReference type="PubMed" id="11895442"/>
<dbReference type="DOI" id="10.1046/j.1432-1327.2002.02817.x"/>
</citation>
<scope>ISOPRENYLATION AT CYS-383</scope>
<scope>MUTAGENESIS OF CYS-383</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="6947" last="6958">
<title>Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation.</title>
<authorList>
<person name="Miggin S.M."/>
<person name="Lawler O.A."/>
<person name="Kinsella B.T."/>
</authorList>
<dbReference type="PubMed" id="12488443"/>
<dbReference type="DOI" id="10.1074/jbc.m210637200"/>
</citation>
<scope>PALMITOYLATION AT CYS-308 AND CYS-311</scope>
<scope>LACK OF PALMITOYLATION AT CYS-309</scope>
<scope>MUTAGENESIS OF CYS-308; CYS-309 AND CYS-311</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Eur. J. Pharmacol." volume="494" first="11" last="22">
<title>Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor.</title>
<authorList>
<person name="Giguere V."/>
<person name="Gallant M.A."/>
<person name="de Brum-Fernandes A.J."/>
<person name="Parent J.-L."/>
</authorList>
<dbReference type="PubMed" id="15194446"/>
<dbReference type="DOI" id="10.1016/j.ejphar.2004.04.041"/>
</citation>
<scope>DISULFIDE BONDS</scope>
</reference>
<comment type="function">
<text>Receptor for prostacyclin (prostaglandin I2 or PGI2). The activity of this receptor is mediated by G(s) proteins which activate adenylate cyclase.</text>
</comment>
<comment type="subunit">
<text evidence="1">Interacts (non-isoprenylated C-terminus) with PDZK1.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="PTM">
<text evidence="5">Palmitoylation of either Cys-308 or Cys-311 is sufficient to maintain functional coupling to G(s) and signaling.</text>
</comment>
<comment type="PTM">
<text evidence="4">Isoprenylation does not influence ligand binding but is required for efficient coupling to the effectors adenylyl cyclase and phospholipase C.</text>
</comment>
<comment type="similarity">
<text evidence="3">Belongs to the G-protein coupled receptor 1 family.</text>
</comment>
<dbReference type="EMBL" id="L29016">
<property type="protein sequence ID" value="AAA36448.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D25418">
<property type="protein sequence ID" value="BAA05008.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D29634">
<property type="protein sequence ID" value="BAA06110.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D38127">
<property type="protein sequence ID" value="BAA07325.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY242134">
<property type="protein sequence ID" value="AAO92301.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC075814">
<property type="protein sequence ID" value="AAH75814.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12686.1"/>
<dbReference type="PIR" id="A57066">
<property type="entry name" value="A57066"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000951.1">
<property type="nucleotide sequence ID" value="NM_000960.3"/>
</dbReference>
<dbReference type="BioGRID" id="111711">
<property type="interactions" value="78"/>
</dbReference>
<dbReference type="IntAct" id="P43119">
<property type="interactions" value="54"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000291294"/>
<dbReference type="BindingDB" id="P43119"/>
<dbReference type="ChEMBL" id="CHEMBL1995"/>
<dbReference type="DrugBank" id="DB05229">
<property type="generic name" value="Beraprost"/>
</dbReference>
<dbReference type="DrugBank" id="DB01160">
<property type="generic name" value="Dinoprost tromethamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01240">
<property type="generic name" value="Epoprostenol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01088">
<property type="generic name" value="Iloprost"/>
</dbReference>
<dbReference type="DrugBank" id="DB11362">
<property type="generic name" value="Selexipag"/>
</dbReference>
<dbReference type="DrugBank" id="DB00374">
<property type="generic name" value="Treprostinil"/>
</dbReference>
<dbReference type="DrugCentral" id="P43119"/>
<dbReference type="GuidetoPHARMACOLOGY" id="345"/>
<dbReference type="GlyGen" id="P43119">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="P43119"/>
<dbReference type="PhosphoSitePlus" id="P43119"/>
<dbReference type="SwissPalm" id="P43119"/>
<dbReference type="BioMuta" id="PTGIR"/>
<dbReference type="DMDM" id="1172500"/>
<dbReference type="MassIVE" id="P43119"/>
<dbReference type="PaxDb" id="P43119"/>
<dbReference type="PeptideAtlas" id="P43119"/>
<dbReference type="PRIDE" id="P43119"/>
<dbReference type="ProteomicsDB" id="55588"/>
<dbReference type="Antibodypedia" id="18117">
<property type="antibodies" value="249 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5739"/>
<dbReference type="Ensembl" id="ENST00000291294">
<property type="protein sequence ID" value="ENSP00000291294"/>
<property type="gene ID" value="ENSG00000160013"/>
</dbReference>
<dbReference type="GeneID" id="5739"/>
<dbReference type="KEGG" id="hsa:5739"/>
<dbReference type="UCSC" id="uc002pex.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5739"/>
<dbReference type="DisGeNET" id="5739"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160013.8"/>
<dbReference type="GeneCards" id="PTGIR"/>
<dbReference type="HGNC" id="HGNC:9602">
<property type="gene designation" value="PTGIR"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160013">
<property type="expression patterns" value="Tissue enhanced (blood, lung)"/>
</dbReference>
<dbReference type="MIM" id="600022">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P43119"/>
<dbReference type="OpenTargets" id="ENSG00000160013"/>
<dbReference type="PharmGKB" id="PA291"/>
<dbReference type="eggNOG" id="KOG3656">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214569"/>
<dbReference type="HOGENOM" id="CLU_045991_0_1_1"/>
<dbReference type="InParanoid" id="P43119"/>
<dbReference type="KO" id="K04263"/>
<dbReference type="OMA" id="RSSVFCI"/>
<dbReference type="OrthoDB" id="972015at2759"/>
<dbReference type="PhylomeDB" id="P43119"/>
<dbReference type="TreeFam" id="TF324982"/>
<dbReference type="PathwayCommons" id="P43119"/>
<dbReference type="Reactome" id="R-HSA-391908">
<property type="pathway name" value="Prostanoid ligand receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-392851">
<property type="pathway name" value="Prostacyclin signalling through prostacyclin receptor"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418555">
<property type="pathway name" value="G alpha (s) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9660821">
<property type="pathway name" value="ADORA2B mediated anti-inflammatory cytokines production"/>
</dbReference>
<dbReference type="SABIO-RK" id="P43119"/>
<dbReference type="SIGNOR" id="P43119"/>
<dbReference type="BioGRID-ORCS" id="5739">
<property type="hits" value="7 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PTGIR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Prostacyclin_receptor"/>
<dbReference type="GenomeRNAi" id="5739"/>
<dbReference type="Pharos" id="P43119">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P43119"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P43119">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160013">
<property type="expression patterns" value="Expressed in left coronary artery and 135 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P43119">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P43119">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005085">
<property type="term" value="F:guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016501">
<property type="term" value="F:prostacyclin receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007189">
<property type="term" value="P:adenylate cyclase-activating G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007187">
<property type="term" value="P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010642">
<property type="term" value="P:negative regulation of platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048662">
<property type="term" value="P:negative regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR000276">
<property type="entry name" value="GPCR_Rhodpsn"/>
</dbReference>
<dbReference type="InterPro" id="IPR017452">
<property type="entry name" value="GPCR_Rhodpsn_7TM"/>
</dbReference>
<dbReference type="InterPro" id="IPR008365">
<property type="entry name" value="Prostanoid_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000370">
<property type="entry name" value="Prostglndn_IP_rcpt"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11866">
<property type="entry name" value="PTHR11866"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11866:SF7">
<property type="entry name" value="PTHR11866:SF7"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00001">
<property type="entry name" value="7tm_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01788">
<property type="entry name" value="PROSTANOIDR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00856">
<property type="entry name" value="PRSTNOIDIPR"/>
</dbReference>
<dbReference type="PROSITE" id="PS00237">
<property type="entry name" value="G_PROTEIN_RECEP_F1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50262">
<property type="entry name" value="G_PROTEIN_RECEP_F1_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0297">G-protein coupled receptor</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0636">Prenylation</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="Prostacyclin receptor" id="PRO_0000070075">
<location>
<begin position="1"/>
<end position="383"/>
</location>
</feature>
<feature type="propeptide" description="Removed in mature form" id="PRO_0000240004" evidence="2">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="1"/>
<end position="16"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="2">
<location>
<begin position="17"/>
<end position="38"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="39"/>
<end position="51"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="2">
<location>
<begin position="52"/>
<end position="76"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="77"/>
<end position="94"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="2">
<location>
<begin position="95"/>
<end position="115"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="116"/>
<end position="134"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="2">
<location>
<begin position="135"/>
<end position="158"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="159"/>
<end position="181"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="2">
<location>
<begin position="182"/>
<end position="208"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="209"/>
<end position="235"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="2">
<location>
<begin position="236"/>
<end position="260"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="261"/>
<end position="274"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="2">
<location>
<begin position="275"/>
<end position="295"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="296"/>
<end position="386"/>
</location>
</feature>
<feature type="site" description="Not S-palmitoylated" evidence="5">
<location>
<position position="309"/>
</location>
</feature>
<feature type="modified residue" description="Cysteine methyl ester" evidence="7">
<location>
<position position="383"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="5">
<location>
<position position="308"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="5">
<location>
<position position="311"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-farnesyl cysteine" evidence="4">
<location>
<position position="383"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="7"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 6">
<location>
<begin position="5"/>
<end position="165"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 6">
<location>
<begin position="92"/>
<end position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229127." id="VAR_024260">
<original>V</original>
<variation>M</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28590598." id="VAR_061226">
<original>S</original>
<variation>W</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced palmitoylation, coupling to G protein unaffected. Abolished palmitoylation and coupling to G protein; when associated with S-311." evidence="5">
<original>C</original>
<variation>S</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on palmitoylation level." evidence="5">
<original>C</original>
<variation>S</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced palmitoylation, coupling to G protein unaffected. Abolished palmitoylation and coupling to G protein; when associated with S-308." evidence="5">
<original>C</original>
<variation>S</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes isoprenylation." evidence="4">
<original>C</original>
<variation>S</variation>
<location>
<position position="383"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00521"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11895442"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12488443"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15194446"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="386" mass="40956" checksum="2B6B0CDBACED1608" modified="1995-11-01" version="1" precursor="true">MADSCRNLTYVRGSVGPATSTLMFVAGVVGNGLALGILSARRPARPSAFAVLVTGLAATDLLGTSFLSPAVFVAYARNSSLLGLARGGPALCDAFAFAMTFFGLASMLILFAMAVERCLALSHPYLYAQLDGPRCARLALPAIYAFCVLFCALPLLGLGQHQQYCPGSWCFLRMRWAQPGGAAFSLAYAGLVALLVAAIFLCNGSVTLSLCRMYRQQKRHQGSLGPRPRTGEDEVDHLILLALMTVVMAVCSLPLTIRCFTQAVAPDSSSEMGDLLAFRFYAFNPILDPWVFILFRKAVFQRLKLWVCCLCLGPAHGDSQTPLSQLASGRRDPRAPSAPVGKEGSCVPLSAWGEGQVEPLPPTQQSSGSAVGTSSKAEASVACSLC</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

